Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Thorac Cancer. 2023 Jul;14(20):1980-1990. doi: 10.1111/1759-7714.14980. Epub 2023 Jun 2.
Thorac Cancer. 2023.
PMID: 37265111
Free PMC article.
CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo.
Zhang K, Wang L, Wei A, Jia X, Liu X.
Zhang K, et al.
Thorac Cancer. 2020 Jun;11(6):1566-1577. doi: 10.1111/1759-7714.13430. Epub 2020 May 5.
Thorac Cancer. 2020.
PMID: 32368855
Free PMC article.
Item in Clipboard
Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy.
Lv P, Yang S, Liu W, Qin H, Tang X, Wu F, Liu Z, Gao H, Liu X.
Lv P, et al.
Thorac Cancer. 2020 Jan;11(1):29-40. doi: 10.1111/1759-7714.13216. Epub 2019 Nov 5.
Thorac Cancer. 2020.
PMID: 31691525
Free PMC article.
Item in Clipboard
Cite
Cite